Prediction of Risk Factors for Coronary Heart Disease Using Framingham Risk Score in Korean Men

被引:10
作者
Ryoo, Jae-Hong [2 ,4 ]
Cho, Soo Hyun [1 ]
Kim, Sang-Wook [3 ]
机构
[1] Chung Ang Univ Hosp, Coll Med, Dept Family Med, Seoul, South Korea
[2] Kyung Hee Univ, Coll Med, Dept Prevent Med, Seoul, South Korea
[3] Chung Ang Univ Hosp, Heart Res Inst, Seoul, South Korea
[4] Sungkyunkwan Univ, Coll Med, Kangbuk Samsung Hosp, Dept Occupat Med, Seoul, South Korea
关键词
APOLIPOPROTEIN-A-I; CARDIOVASCULAR-DISEASE; LIPOPROTEIN CHOLESTEROL; LIFE-STYLE; ATHEROSCLEROSIS; THERAPY; TARGETS; RATIO;
D O I
10.1371/journal.pone.0045030
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Currently, there is sparse data available on the relationship between coronary heart disease (CHD) and its risk factors estimated by the Framingham Risk Score (FRS) in Korea. This is particularly true when looking at risk factors of CHD associated with the FRS after adjustment for other covariates especially in healthy subjects. Methodology/Principal Findings: We conducted a prospective cohort study to examine the association between the risk factors of CHD and the risk for CHD estimated by FRS in 15,239 men in 2005 and 2010. The FRS is based on six coronary risk factors: gender, age, total cholesterol, high-density lipoprotein (HDL)-cholesterol, systolic blood pressure (BP), and smoking habit. Multiple linear regression analysis was used to analyze the relationships between the FRS and risk factors for CHD. This study reported that apolipoproetein B (apoB), apoA-I, apoB/apoA-I, alcohol intake, log-transformed TG, log-transformed hsCRP, LDL-cholesterol, hypertension, diabetes, regular exercise, and BMI were significantly associated with the FRS. Above all, the partial R-square of apoB was 14.77%, which was overwhelmingly bigger than that of other variables in model V. This indicated that apoB accounted for 14.77% of the variance in FRS. Conclusion/Significance: In this study, apoB was found to be the most important determinant for the future development of CHD during a 5-year follow-up in healthy Korean men.
引用
收藏
页数:5
相关论文
共 29 条
[1]   CARDIOVASCULAR-DISEASE RISK PROFILES [J].
ANDERSON, KM ;
ODELL, PM ;
WILSON, PWF ;
KANNEL, WB .
AMERICAN HEART JOURNAL, 1991, 121 (01) :293-298
[2]  
Bachorik PS, 1997, CLIN CHEM, V43, P2364
[3]   Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel [J].
Barter, PJ ;
Ballantyne, CM ;
Carmena, R ;
Cabezas, MC ;
Chapman, MJ ;
Couture, P ;
De Graaf, J ;
Durrington, PN ;
Faergeman, O ;
Frohlich, J ;
Furberg, CD ;
Gagne, C ;
Haffner, SM ;
Humphries, SE ;
Jungner, I ;
Krauss, RM ;
Kwiterovich, P ;
Marcovina, S ;
Packard, CJ ;
Pearson, TA ;
Reddy, KS ;
Rosenson, R ;
Sarrafzadegan, N ;
Sniderman, AD ;
Stalenhoef, AF ;
Stein, E ;
Talmud, PJ ;
Tonkin, AM ;
Walldius, G ;
Williams, KMS .
JOURNAL OF INTERNAL MEDICINE, 2006, 259 (03) :247-258
[4]   Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B -: The Copenhagen city heart study [J].
Benn, Marianne ;
Nordestgaard, Borge G. ;
Jensen, Gorm Boje ;
Tybjærg-Hansen, Anne .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (03) :661-670
[5]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[6]   INVESTIGATION OF CORONARY HEART-DISEASE IN FAMILIES - FRAMINGHAM OFFSPRING STUDY [J].
KANNEL, WB ;
FEINLEIB, M ;
MCNAMARA, PM ;
GARRISON, RJ ;
CASTELLI, WP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1979, 110 (03) :281-290
[7]   Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men - Prospective results from the Quebec Cardiovascular Study [J].
Lamarche, B ;
Tchernof, A ;
Moorjani, S ;
Cantin, B ;
Dagenais, GR ;
Lupien, PJ ;
Despres, JP .
CIRCULATION, 1997, 95 (01) :69-75
[8]   Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study [J].
Lamarche, B ;
Moorjani, S ;
Lupien, PJ ;
Cantin, B ;
Bernard, PM ;
Dagenais, GR ;
Despres, JP .
CIRCULATION, 1996, 94 (03) :273-278
[9]   Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels [J].
Marcovina, S ;
Packard, CJ .
JOURNAL OF INTERNAL MEDICINE, 2006, 259 (05) :437-446
[10]  
MARCOVINA SM, 1994, CLIN CHEM, V40, P586